secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001193125-24-011747
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC raises $125M in private placement; extends cash runway into late 2026
--------------------------------------------------------------------------

- Sold 12.5M shares at $10.00 each; gross proceeds approx. $125M.
- Investors include Viking Global, Commodore, Frazier, Venrock, NEA, Nextech.
- Premium of ~10% to ORIC's 5-day trailing average price.
- Pro forma cash expected to fund operating plan into late 2026.
- Private placement expected to close on January 23, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312524011747/0001193125-24-011747-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312524011747/d737340d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-011747

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer